Results 13,741-13,760 of 49,836 for speaker:Stephen Donnelly

Written Answers — Department of Health: Departmental Staff (21 Mar 2023)

Stephen Donnelly: The Department of Health recognises the key role of Pharmacy in the Community, and the ongoing significant contribution made by this sector to patients and the public, particularly during the pandemic. The potential role that pharmacy may play in the development and implementation of future healthcare reform, especially in regard to the aims and vision of Sláintecare, is under...

Written Answers — Department of Health: Pharmacy Services (21 Mar 2023)

Stephen Donnelly: I propose to take Questions Nos. 1322, 1324 and 1325 together. As Minister for Health, I recognise the significant role community pharmacists play in the delivery of patient care and acknowledge the potential for this role to be developed further in the context of health service reform. Their participation in the national COVID-19 vaccination rollout – the largest ever undertaken by...

Written Answers — Department of Health: Pharmacy Services (21 Mar 2023)

Stephen Donnelly: Thank you for your question - the number of registered pharmacists on the Register of Pharmacists held and maintained by the Pharmaceutical Society of Ireland (PSI), the pharmacy regulator has continued to grow steadily over the past five years with 7083 pharmacists registered with the PSI on the 1 March 2023, under established processes based in Irish and EU law. The Pharmacy Act 2007,...

Written Answers — Department of Health: Pharmacy Services (21 Mar 2023)

Stephen Donnelly: In the case of medicines used most often in Ireland, there are typically multiple forms, strengths, brands, and generic medicines available from various sources. Where some individual medicines are in short supply, alternative options such as alternative strengths, brands, and generic medicines remain available to ensure continuity of treatment. In other jurisdictions shortages...

Written Answers — Department of Health: Medicinal Products (21 Mar 2023)

Stephen Donnelly: The purpose of a national prescribing service is to provide guidance to prescribers in making optimum use of available medicines. In Ireland, the Health Service Executive’s (HSE) Medicines Management Programme (MMP) performs this role. Their remit is the enhancement of safe, effective, and cost-effective use of medicines in Irish healthcare. The MMP have identified preferred...

Written Answers — Department of Health: Irish Language (21 Mar 2023)

Stephen Donnelly: Section 12 of the Public Health (Alcohol) Act 2018 requires that certain health warnings and information be displayed on the labels of alcohol products, on notices in licensed premises and on websites which sell alcohol products. The labels of alcohol products must also contain information on the grams of alcohol and the calories in the product. Section 12 requires that the notices to be...

Written Answers — Department of Health: Covid-19 Pandemic (21 Mar 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly.

Written Answers — Department of Health: Covid-19 Pandemic (21 Mar 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly.

Written Answers — Department of Health: Medicinal Products (21 Mar 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. The HSE does not supply vaccines or provide reimbursement support for vaccines through community pharmacies under the Statutory Drug Schemes. When the public...

Written Answers — Department of Health: Medicinal Products (21 Mar 2023)

Stephen Donnelly: I recently announced my intention to bring forward a successor plan to the existing National Rare Disease Plan 2014 - 2018. While this work was delayed by the pandemic, the Government has continued to invest significant resources in the area of new medicines in recent years. In 2021 nineteen (19) orphan medicines for rare diseases were added to the reimbursement list. In 2022, the number was...

Written Answers — Department of Health: Healthcare Infrastructure Provision (21 Mar 2023)

Stephen Donnelly: I can confirm that The Health Service Executive’s Capital Plan 2023, as a related document of the National Service Plan, has been submitted to me for my review and approval. Capital core funding allocated in 2023 for the construction and equipping of healthcare facilities is €967m, an increase of 11% over 2022 core allocation plus an amount of €50m for Covid...

Written Answers — Department of Health: Health Services Staff (21 Mar 2023)

Stephen Donnelly: Senior Officials in my Department continue in their efforts to ensure this matter can be brought to a satisfactory resolution as quickly as possible in compliance with the recommendations outlined in LCR19986, whilst taking account of the part settlement acknowledged by FORSA in their letter to the HSE on 13th April last. 13th April 2022 Re: Forsa Sectoral Bargaining Units Dear Paul, I refer...

Written Answers — Department of Health: Disability Services (21 Mar 2023)

Stephen Donnelly: As this is a operational matter, I have referred it to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Disability Services (21 Mar 2023)

Stephen Donnelly: As the Health Service Executive (HSE) have responsibility for the provision of aids and appliances under the Community Funded Schemes, I have asked the HSE to respond to the Deputy directly as soon as possible.

Written Answers — Department of Health: Medicinal Products (21 Mar 2023)

Stephen Donnelly: The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. HSE decisions on which medicines are reimbursed by the taxpayer are made on objective, scientific and economic grounds, on the advice of the National Centre for Pharmacoeconomics (NCPE)....

Written Answers — Department of Health: Health Services Staff (21 Mar 2023)

Stephen Donnelly: As this is an administrative matter for the Health Service Executive, I have asked the HSE to respond directly to the Deputy.

Written Answers — Department of Health: Medicinal Products (21 Mar 2023)

Stephen Donnelly: There are no plans to make the provision of hormone replacement therapy (HRT) medications free of charge. However, as announced in Budget 2023, the VAT rate for non-oral forms of HRT was reduced to zero from 1 January 2023. The Health Service Executive (HSE) has statutory responsibility for pricing and reimbursement decisions under the community drug schemes, in accordance with the...

Written Answers — Department of Health: Health Services (21 Mar 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Covid-19 Pandemic (21 Mar 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly. I would also like to remind the Deputy that it is against Department policy to comment on individual cases.

Written Answers — Department of Health: Hospital Staff (21 Mar 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the deputy directly, as soon as possible.